Unknown

Dataset Information

0

Metabolic Drug Response Phenotyping in Colorectal Cancer Organoids by LC-QTOF-MS.


ABSTRACT: As metabolic rewiring is crucial for cancer cell proliferation, metabolic phenotyping of patient-derived organoids is desirable to identify drug-induced changes and trace metabolic vulnerabilities of tumor subtypes. We established a novel protocol for metabolomic and lipidomic profiling of colorectal cancer organoids by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) facing the challenge of capturing metabolic information from a minimal sample amount (<500 cells/injection) in the presence of an extracellular matrix (ECM). The best procedure of the tested protocols included ultrasonic metabolite extraction with acetonitrile/methanol/water (2:2:1, v/v/v) without ECM removal. To eliminate ECM-derived background signals, we implemented a data filtering procedure based on the p-value and fold change cut-offs, which retained features with signal intensities >120% compared to matrix-derived signals present in blank samples. As a proof-of-concept, the method was applied to examine the early metabolic response of colorectal cancer organoids to 5-fluorouracil treatment. Statistical analysis revealed dose-dependent changes in the metabolic profiles of treated organoids including elevated levels of 2'-deoxyuridine, 2'-O-methylcytidine, inosine and 1-methyladenosine and depletion of 2'-deoxyadenosine and specific phospholipids. In accordance with the mechanism of action of 5-fluorouracil, changed metabolites are mainly involved in purine and pyrimidine metabolism. The novel protocol provides a first basis for the assessment of metabolic drug response phenotypes in 3D organoid models.

SUBMITTER: Neef SK 

PROVIDER: S-EPMC7760698 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Metabolic Drug Response Phenotyping in Colorectal Cancer Organoids by LC-QTOF-MS.

Neef Sylvia K SK   Janssen Nicole N   Winter Stefan S   Wallisch Svenja K SK   Hofmann Ute U   Dahlke Marc H MH   Schwab Matthias M   Mürdter Thomas E TE   Haag Mathias M  

Metabolites 20201201 12


As metabolic rewiring is crucial for cancer cell proliferation, metabolic phenotyping of patient-derived organoids is desirable to identify drug-induced changes and trace metabolic vulnerabilities of tumor subtypes. We established a novel protocol for metabolomic and lipidomic profiling of colorectal cancer organoids by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) facing the challenge of capturing metabolic information from a minimal sample amount (<500 cells/in  ...[more]

Similar Datasets

2021-10-12 | MTBLS2130 | MetaboLights
| S-EPMC8295757 | biostudies-literature
| S-EPMC8267200 | biostudies-literature
| S-EPMC7322743 | biostudies-literature
| S-EPMC7813710 | biostudies-literature
| S-EPMC6317967 | biostudies-literature
| S-EPMC6936316 | biostudies-literature
| S-EPMC8035671 | biostudies-literature
| S-EPMC4344598 | biostudies-literature
| S-EPMC7125068 | biostudies-literature